Money and Me: How is Guardant Health improving clinical outcomes for cancer patients?
Simranjit Singh is the CEO of Guardant Health, a precision oncology company that launched the first FDA-approved blood test for genomic testing across all solid cancers about 2 years ago. And just rec...
29 Aug 20229min
Market View Minute: Thompson Medical Groups surge in profits
Running vaccination clinics pays off for Thomson Medical which is reporting banner profits and dividends. How much? Michelle Martin finds out in Market View MinutesSee omnystudio.com/listener for priv...
29 Aug 20222min
Money and Me: Struggling to monetise your content?
While the Creator landscape is estimated to reach a global market size of US$104 billion by the end of 2022, it looks like many creators still struggle with the transition to creating content as a ful...
26 Aug 202216min
Market View: Grab, GOTO, PropertyGuru
In this episode of Market View, we take a look at the current state of business for Grab, GOTO and Property Guru and who is gaining traction and who isn't? Then we survey US markets; US stocks rallied...
26 Aug 20224min
Market View Minutes: Singpost in one basket?
A man sold his HDB flat and invested the entire sum in just one stock: SingPost. Wow, that’s confidence... or something else, depending on how you look at it. So, how has SingPost done since he boug...
26 Aug 20223min
Read: Build For Tomorrow by Jason Feifer
Is reducing the fear of loss an important key to dealing with change? Jason Feifer goes beyond the page of his new book with Michelle Martin in this interview. Michelle says this transformative book s...
26 Aug 202220min
Money and Me: The best strategy to stay on course with investments during an inflation
From a Singaporean who recently became one of the biggest shareholders of Singpost after selling his flat, to China’s Pinduoduo taking its first international step in the US market, and what investors...
25 Aug 202224min
Market View: Twitter episode key takeaways, Noble Group's bust, Intel, Nvidia, Snowflake, Singtel
What are some of the key takeaways of the Musk-Twitter drama? And how do Noble Group's penalties compare to their crime? Michelle Martin and Ryan Huang explore the latest happenings in the market and ...
25 Aug 202217min
